Anti-inflammatory effect of fluvastatin on polarized macrophages and its dependence on the mevalonate pathway
Authors:
Open Access
- 2 June 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Abstract
The study focuses on the effects of fluvastatin on immunomarkers of the M1 and M2 macrophages and its direct role in macrophage (M0) polarization. Moreover, it investigates the dependency of immunomodulatory properties of fluvastatin on the mevalonate pathway. Macrophages (M0, M1, M2), differentiated from human blood monocytes, were treated with fluvastatin. Mevalonate and geranylgeranyl pyrophosphate intermediates were introduced to assess the mevalonate pathway dependence. The immunomarkers were evaluated with qPCR, ELISA, Griess assay, and flow cytometry. Fluvastatin significantly reduces the pro-inflammatory gene expression (NFκB, IL-1β, IL-6, iNOS) in M1 while enhancing the anti-inflammatory markers (Arg-1, TGFβ) in M2 macrophages. The production of the TNFα, IL-1β, and IL-6 cytokines is reduced in M1, and IL-10 production increased in M2 macrophages. Fluvastatin decreases the iNOS activity in M1 macrophages. The intermediates reverse the fluvastatin’s effects on anti-inflammatory gene expression by M2 macrophages, cytokine production (by M1 and M2 macrophages), and iNOS activity (by M1 macrophages). Their impact on surface marker expression was somewhat limited. These findings demonstrate that fluvastatin exerts anti-inflammatory effects on polarized macrophages without affecting polarization per se and also highlight the dependency on the mevalonate pathway. This study deepens the understanding of statins’ immunomodulatory mechanisms, suggesting potential applications in treating inflammatory diseases.Keywords
Funding Information
- European Union – Next Generation EU (LX22NPO5104)
This publication has 50 references indexed in Scilit:
- Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelinesSaudi Pharmaceutical Journal, 2023
- Simvastatin Inhibits IL-1β-Induced Apoptosis and Extracellular Matrix Degradation by Suppressing the NF-kB and MAPK Pathways in Nucleus Pulposus CellsInflammation, 2017
- Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cellsNeuroscience, 2016
- Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravisMolecular and Cellular Neuroscience, 2015
- Statins in therapy: Understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studiesEuropean Journal of Medicinal Chemistry, 2014
- Statins are associated with reduced use of steroids in inflammatory bowel disease: A retrospective cohort study*Inflammatory Bowel Diseases, 2012
- Statins enhance toll‐like receptor 4‐mediated cytokine gene expression in astrocytes: Implication of Rho proteins in negative feedback regulationJournal of Neuroscience Research, 2007
- Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug–drug interactions and interindividual differences in transporter and metabolic enzyme functionsPharmacology & Therapeutics, 2006
- Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)—Can C-Reactive Protein Be Used to Target Statin Therapy in Primary Prevention?The American Journal of Cardiology, 2006
- The origin of the statinsInternational Congress Series, 2004